Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Growing at an Attractive Rate, the Fluorescent Imaging Research Market Presents Promising Opportunities for New Product



  Growing at an Attractive Rate, the Fluorescent Imaging Research Market
  Presents Promising Opportunities for New Product Development According to
  Percepta

 Life Technologies Dominates Market, While Abcam and BD Biosciences Maintain
                               Strong Presence

Business Wire

CARLSBAD, Calif. -- March 11, 2013

Percepta Associates announces the launch of its Fluorescent Imaging Life
Science Dashboard™ market research report revealing Life Technologies, Abcam
and BD Biosciences as leading suppliers across various segments. Market
segments analyzed in this report include: fluorescence microscopy
/immunofluorescence, high content screening, fluorescent immunohistochemistry,
and fluorescent in situ hybridization (FISH). Sigma Aldrich and
PerkinElmer/Caliper supplant Abcam and BD Biosciences as leading suppliers in
the fluorescent small animal in vivo imaging product segment.

“With double digit annual growth rates, moderate satisfaction levels and
relatively high interest in switching for several fluorescent imaging segments
being expressed by a significant percentage of the population surveyed, a need
for new and improved products is evident,” said Sarab Khandpur, Senior Analyst
and Editor of the Life Science Dashboard™ publications. “This 2013 Fluorescent
Imaging Life Science Dashboard^TM report provides a detailed analysis of end
user practices and preferences for key segments.”

Designed and executed by individuals with practical industry experience, this
report contains strategically grounded findings that simplify business
planning with confidence and certainty.

The report is a comprehensive survey of over 460 academic and commercial
research scientists in North America and Europe, which illuminates several key
market indices such as:

  * Overall and segment market sizes & market growth rates
  * Share of mentions & dyes/compounds used
  * Reaction throughput rates
  * Customer satisfaction & propensity to switch suppliers
  * Competitive landscape*
  * Perceived pricing
  * Technique usage frequency
  * Research focus and target of fluorescent experiments
  * Desired product changes

*Companies cited by respondents in this report include:

  * Abcam
  * Affymetrix/eBioscience
  * BD Biosciences
  * Biotium
  * EMD/Millipore
  * GE Healthcare/Amersham
  * Jackson Immunoresearch Laboratories
  * Kirkegaard & Perry Laboratories
  * Life Technologies/Invitrogen/Molecular Probes
  * PerkinElmer/Caliper
  * R&D Systems
  * Santa Cruz Biotechnology
  * Sigma Aldrich (NASDAQ:SIAL)
  * Thermo Fisher Scientific/Cellomics/Pierce (NYSE: TMO)
  * Vector Laboratories

To view the 2013 Fluorescent Imaging Dashboard^TM sample data and
questionnaire, please click on the link below:

http://www.perceptaassociates.com/reports/2013-fluorescent-imaging-dashboard-series-1-na-eu/

About Percepta

Founded in 2005 in Carlsbad, California Percepta is a specialized consultancy
providing market assessment, product development and pricing, brand assessment
and development, market planning, ad concept and message testing and due
diligence services to life science research suppliers globally. For more
information visit: www.perceptaassociates.com or call 877 597 9236.

Contact:

Percepta Associates Inc.
Anne St Louis
Director
877-597-9236
AStlouis@perceptaassociates.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement